Randomized trial of inactivated and live polio vaccine schedules in guatemalan infants

Edwin J. Asturias, Erica L. Dueger, Saad B. Omer, Arturo Melville, Silvia V. Nates, Majid Laassri, Konstantin Chumakov, Neal A Halsey

Research output: Contribution to journalArticle

Abstract

Background. The immunogenicity of inactivated poliovirus vaccine (IPV) in developing countries is not well documented. This study compared the immune response to IPV with that to oral poliovirus vaccine (OPV) in Guatemalan infants. Methods. This was an open-label, randomized comparison of IPV only, OPV only, or IPV followed by OPV in Guatemalan public health clinics. Serum samples were tested for neutralizing antibodies, and stool samples were tested for Sabin strain polioviruses. Results. Seropositivity rates 2 months after 2 doses of IPV were 98%-100% for polio types 1, 2, and 3 and were 97.1%, 99.3%, and 92.1% for OPV-only recipients (P <.001 for the response to type 3). One month after the third dose, 100% of IPV-only recipients had protective antibodies against all 3 types, compared with 99%, 100%, and 97% against polio types 1, 2, and 3 respectively, among recipients of OPV only. Infants who received IPV only had higher geometric mean titers than infants who received OPV only. Maternal antibodies lowered the final antibody responses to IPV but did not prevent the development of protective levels of antibody. Of 191 stool samples from infants who received IPV only, 5 (2.6%) were positive for poliovirus vaccine strains. Conclusions. IPV alone and IPV followed by OPV are safe and effective for Guatemalan infants.

Original languageEnglish (US)
Pages (from-to)692-698
Number of pages7
JournalJournal of Infectious Diseases
Volume196
Issue number5
DOIs
StatePublished - Sep 1 2007

Fingerprint

Inactivated Poliovirus Vaccine
Poliomyelitis
Oral Poliovirus Vaccine
Appointments and Schedules
Vaccines
Antibodies
Poliovirus Vaccines
Poliovirus
Neutralizing Antibodies
Developing Countries
Antibody Formation

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Asturias, E. J., Dueger, E. L., Omer, S. B., Melville, A., Nates, S. V., Laassri, M., ... Halsey, N. A. (2007). Randomized trial of inactivated and live polio vaccine schedules in guatemalan infants. Journal of Infectious Diseases, 196(5), 692-698. https://doi.org/10.1086/520546

Randomized trial of inactivated and live polio vaccine schedules in guatemalan infants. / Asturias, Edwin J.; Dueger, Erica L.; Omer, Saad B.; Melville, Arturo; Nates, Silvia V.; Laassri, Majid; Chumakov, Konstantin; Halsey, Neal A.

In: Journal of Infectious Diseases, Vol. 196, No. 5, 01.09.2007, p. 692-698.

Research output: Contribution to journalArticle

Asturias, EJ, Dueger, EL, Omer, SB, Melville, A, Nates, SV, Laassri, M, Chumakov, K & Halsey, NA 2007, 'Randomized trial of inactivated and live polio vaccine schedules in guatemalan infants', Journal of Infectious Diseases, vol. 196, no. 5, pp. 692-698. https://doi.org/10.1086/520546
Asturias EJ, Dueger EL, Omer SB, Melville A, Nates SV, Laassri M et al. Randomized trial of inactivated and live polio vaccine schedules in guatemalan infants. Journal of Infectious Diseases. 2007 Sep 1;196(5):692-698. https://doi.org/10.1086/520546
Asturias, Edwin J. ; Dueger, Erica L. ; Omer, Saad B. ; Melville, Arturo ; Nates, Silvia V. ; Laassri, Majid ; Chumakov, Konstantin ; Halsey, Neal A. / Randomized trial of inactivated and live polio vaccine schedules in guatemalan infants. In: Journal of Infectious Diseases. 2007 ; Vol. 196, No. 5. pp. 692-698.
@article{0ea34009c4d94783aaac072ae9c008d8,
title = "Randomized trial of inactivated and live polio vaccine schedules in guatemalan infants",
abstract = "Background. The immunogenicity of inactivated poliovirus vaccine (IPV) in developing countries is not well documented. This study compared the immune response to IPV with that to oral poliovirus vaccine (OPV) in Guatemalan infants. Methods. This was an open-label, randomized comparison of IPV only, OPV only, or IPV followed by OPV in Guatemalan public health clinics. Serum samples were tested for neutralizing antibodies, and stool samples were tested for Sabin strain polioviruses. Results. Seropositivity rates 2 months after 2 doses of IPV were 98{\%}-100{\%} for polio types 1, 2, and 3 and were 97.1{\%}, 99.3{\%}, and 92.1{\%} for OPV-only recipients (P <.001 for the response to type 3). One month after the third dose, 100{\%} of IPV-only recipients had protective antibodies against all 3 types, compared with 99{\%}, 100{\%}, and 97{\%} against polio types 1, 2, and 3 respectively, among recipients of OPV only. Infants who received IPV only had higher geometric mean titers than infants who received OPV only. Maternal antibodies lowered the final antibody responses to IPV but did not prevent the development of protective levels of antibody. Of 191 stool samples from infants who received IPV only, 5 (2.6{\%}) were positive for poliovirus vaccine strains. Conclusions. IPV alone and IPV followed by OPV are safe and effective for Guatemalan infants.",
author = "Asturias, {Edwin J.} and Dueger, {Erica L.} and Omer, {Saad B.} and Arturo Melville and Nates, {Silvia V.} and Majid Laassri and Konstantin Chumakov and Halsey, {Neal A}",
year = "2007",
month = "9",
day = "1",
doi = "10.1086/520546",
language = "English (US)",
volume = "196",
pages = "692--698",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Randomized trial of inactivated and live polio vaccine schedules in guatemalan infants

AU - Asturias, Edwin J.

AU - Dueger, Erica L.

AU - Omer, Saad B.

AU - Melville, Arturo

AU - Nates, Silvia V.

AU - Laassri, Majid

AU - Chumakov, Konstantin

AU - Halsey, Neal A

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Background. The immunogenicity of inactivated poliovirus vaccine (IPV) in developing countries is not well documented. This study compared the immune response to IPV with that to oral poliovirus vaccine (OPV) in Guatemalan infants. Methods. This was an open-label, randomized comparison of IPV only, OPV only, or IPV followed by OPV in Guatemalan public health clinics. Serum samples were tested for neutralizing antibodies, and stool samples were tested for Sabin strain polioviruses. Results. Seropositivity rates 2 months after 2 doses of IPV were 98%-100% for polio types 1, 2, and 3 and were 97.1%, 99.3%, and 92.1% for OPV-only recipients (P <.001 for the response to type 3). One month after the third dose, 100% of IPV-only recipients had protective antibodies against all 3 types, compared with 99%, 100%, and 97% against polio types 1, 2, and 3 respectively, among recipients of OPV only. Infants who received IPV only had higher geometric mean titers than infants who received OPV only. Maternal antibodies lowered the final antibody responses to IPV but did not prevent the development of protective levels of antibody. Of 191 stool samples from infants who received IPV only, 5 (2.6%) were positive for poliovirus vaccine strains. Conclusions. IPV alone and IPV followed by OPV are safe and effective for Guatemalan infants.

AB - Background. The immunogenicity of inactivated poliovirus vaccine (IPV) in developing countries is not well documented. This study compared the immune response to IPV with that to oral poliovirus vaccine (OPV) in Guatemalan infants. Methods. This was an open-label, randomized comparison of IPV only, OPV only, or IPV followed by OPV in Guatemalan public health clinics. Serum samples were tested for neutralizing antibodies, and stool samples were tested for Sabin strain polioviruses. Results. Seropositivity rates 2 months after 2 doses of IPV were 98%-100% for polio types 1, 2, and 3 and were 97.1%, 99.3%, and 92.1% for OPV-only recipients (P <.001 for the response to type 3). One month after the third dose, 100% of IPV-only recipients had protective antibodies against all 3 types, compared with 99%, 100%, and 97% against polio types 1, 2, and 3 respectively, among recipients of OPV only. Infants who received IPV only had higher geometric mean titers than infants who received OPV only. Maternal antibodies lowered the final antibody responses to IPV but did not prevent the development of protective levels of antibody. Of 191 stool samples from infants who received IPV only, 5 (2.6%) were positive for poliovirus vaccine strains. Conclusions. IPV alone and IPV followed by OPV are safe and effective for Guatemalan infants.

UR - http://www.scopus.com/inward/record.url?scp=34548093764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548093764&partnerID=8YFLogxK

U2 - 10.1086/520546

DO - 10.1086/520546

M3 - Article

VL - 196

SP - 692

EP - 698

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -